<?xml version="1.0" encoding="UTF-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 C:\PWang\Datasets\grobid-0.5.5\grobid-0.5.5\grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<encodingDesc>
			<appInfo>
				<application version="0.5.5" ident="GROBID" when="2020-06-22T14:02+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Simultaneous Detection and Differentiation of Human Papillomavirus Genotypes 6, 11, 16 and 18 by AllGlo Quadruplex Quantitative PCR</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daojun</forename><surname>Yu</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="laboratory">State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases</orgName>
								<orgName type="institution" key="instit1">The First Affiliated Hospital</orgName>
								<orgName type="institution" key="instit2">Zhejiang University</orgName>
								<address>
									<settlement>Hangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Clinical Laboratories</orgName>
								<orgName type="institution">Hangzhou First People&apos;s Hospital</orgName>
								<address>
									<settlement>Hangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu</forename><surname>Chen</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="laboratory">State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases</orgName>
								<orgName type="institution" key="instit1">The First Affiliated Hospital</orgName>
								<orgName type="institution" key="instit2">Zhejiang University</orgName>
								<address>
									<settlement>Hangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shenghai</forename><surname>Wu</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Clinical Laboratories</orgName>
								<orgName type="institution">Hangzhou First People&apos;s Hospital</orgName>
								<address>
									<settlement>Hangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Baohong</forename><surname>Wang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="laboratory">State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases</orgName>
								<orgName type="institution" key="instit1">The First Affiliated Hospital</orgName>
								<orgName type="institution" key="instit2">Zhejiang University</orgName>
								<address>
									<settlement>Hangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yi-Wei</forename><surname>Tang</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Clinical Microbiology Service</orgName>
								<orgName type="institution">Memorial Sloan-Kettering Cancer Center</orgName>
								<address>
									<settlement>New York</settlement>
									<region>New York</region>
									<country>United States of America</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lanjuan</forename><surname>Li</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="laboratory">State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases</orgName>
								<orgName type="institution" key="instit1">The First Affiliated Hospital</orgName>
								<orgName type="institution" key="instit2">Zhejiang University</orgName>
								<address>
									<settlement>Hangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Simultaneous Detection and Differentiation of Human Papillomavirus Genotypes 6, 11, 16 and 18 by AllGlo Quadruplex Quantitative PCR</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abstract</head><p>Background: Human papillomaviruses (HPV) are classified into high-risk HPV and low-risk HPV. The most common high-risk HPV types in cervical cancer are HPV 16 and 18, and the most common low-risk types causing genital warts are HPV 6 and HPV 11. In this study, applying novel AllGlo fluorescent probes, we established a quadruplex quantitative PCR method to simultaneously detect and differentiate HPV 6, 11, 16 and 18 in a single tube.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>More than 120 Human papillomaviruses (HPV) genotypes have been found throughout the world. The most common high-risk HPV types in cervical cancer are HPV 16 and 18, and the most common low-risk types causing genital warts are HPV 6 and HPV 11 <ref type="bibr" target="#b0">[1]</ref>. Some studies suggest that about 70% of cervical epithelial cell dysplasia and cervical cancer is closely related to HPV 16 and 18 infection, while more than 90% of external genital warts is caused by HPV 6 and 11 infection <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3]</ref>. HPV 16 and 18 are regarded as high-risk HPV, while HPV 6 and 11 are thought as low-risk HPV <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref>. A persistent infection may generate a particularly high HPV DNA load through viral replication <ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref>. Because HPV 6 or 11 can cause genital warts and HPV 16 or 18 may lead cervical cancer, preventing infections from these viruses can be an effective way to control the incidence of cervical cancer and cauliflower excrescence. A natural HPV-infection gives little or none protection against new infections due to low immune response, but the HPV-vaccine does.Several HPV vaccines are commercially available <ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref> and have been shown to be effective in preventing infections caused by HPV 6, 11, 16 and 18, There are already several commercial tests for HPV 6, 11, 16 and 18 available. It is obvious a marked progression for these tests. This assay will facilitate molecular epidemiological studies and drug development.</p><p>HPV genotyping is mainly determined by molecular methods of detecting viral DNA <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref>. The multiplex real-time fluorescence quantitative PCR (qPCR) technique is an effective method which can simultaneously type many viruses <ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref>. However, existing qPCR has some disadvantages such as low throughput <ref type="bibr" target="#b24">[25,</ref><ref type="bibr" target="#b25">26]</ref>, complicated techniques <ref type="bibr" target="#b26">[27,</ref><ref type="bibr" target="#b27">28]</ref>, and expensive reagents <ref type="bibr" target="#b26">[27,</ref><ref type="bibr" target="#b28">29]</ref>. Moreover, it was not able to type four HPV viruses simultaneously in a single tube in a quantitative manner <ref type="bibr" target="#b25">[26]</ref> in order to meet the requirement for detecting multiple subtypes of HPV in a clinical setting.</p><p>The AllGlo probe is the latest generation of fluorescent quantitative probes developed by AlleLogic Biosciences Corporation (Hayward, California). It replaces the quencher with a fluorophore that is identical the first fluorophore. Both of the fluorophores are in a quenched state when the probe is intact, but become dequenched when the probe is cleaved. An AllGlo probe generates two light-emitting fluorophores per cleavage event, leading to greater fluorescence gain in fluorescence PCR and lower Ct value <ref type="figure" target="#fig_0">(Figure 1</ref>). In addition, the optimal Tm of the oligonucleotide of the AllGlo probe is the same temperature for annealing/extension, not ten degrees higher as is required for TaqMan. As a result, AllGlo probes tend to be shorter, usually 15-16 nucleotides long. This short oligonucleotide is advantageous in single mismatch discrimination. So AllGlo quadruplex quantitative PCR has the advantages of relatively high throughput, good reproducibility, high sensitivity, high specificity, it is easy for designing the probes and primers of multiplex qPCR and can increase the detection throughput.</p><p>In this study, we used AllGlo probe and developed a method to simultaneously detect four types of HPV <ref type="bibr">(HPV 6,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b17">18)</ref> in a single-tube format. This quadruplex assay was validated with an existing uniplex TaqMan assay and a HPV GA test. We carried out a series of control experiments and demonstrated the high specificity, sensitivity, and repeatability of this approach.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical Specimens</head><p>Clinical specimens which included vaginal secretions (220 specimens), leucorrhoea (30 specimens), cauliflower excrescence warts (200 specimens), and other tissues (10 specimens)were collected from Hangzhou First People's Hospital, China. The patients(210 M, 250F) aged 20 to 50 years.Informed written consent to utilize their specimens for this study was obtained from the patients (Approved by the Ethics Review Committee of Hangzhou First People's Hospital). After pre-treatment, all of the specimens were subject to DNA extraction, to detection of HPV genotype by HPV GA test (Hybribio Ltd., Hong Kong), and then to quantitative detection of viral loads (only <ref type="bibr">HPV 6,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr">16 and 18)</ref> by fluorescence quantitative PCR (Da'an reagent, Guangzhou Da'an Diagnostic Co., Ltd., China). The positive samples with known concentrations were conserved at -80 uC for future use.  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Construction of Plasmids Containing HPV Genes</head><p>We used PCR to gain anticipated size of DNA fragments for each HPV target gene <ref type="table" target="#tab_0">(Table 1)</ref> and then ligated to PMD-19T plasmids at 16uC overnight. The ligated products were transformed into E. coli DH5a and plated on LB plates containing l00 mg/L ampicillin. Plasmid DNA was extracted from bacterial culture using an extraction kit (TaKaRa reagent). The plasmid insert DNA sequences (Supporting Information S1) were confirmed by Sanger sequencing (Invitrogen Biotechnology Shanghai, China). The plasmid DNA samples from positive clones were quantified by UV spectrophotometry. Plasmids were diluted to 10 10 copies/ml in TE (pH 8.0) buffer for storage at -20uC.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Extraction of the DNA Template from Clinical Specimens</head><p>Secretion swab specimens were dissolved in normal saline. Tissues and cauliflower excrescence warts were infiltrated in 4% sodium hydroxide solution and comminuted with metal bar. The dissolved samples were oscillated and resuspended for 1 min, followed by centrifuging for 5 min (4 uC, 12,0006g/min). The supernatant was discarded, and the sediment was resuspended in 50 ml of DNA extraction solution (Guangzhou Da'an Diagnostic Co., Ltd., China). After heating at 100 uC for 10 min, the sample was centrifuged for 5 min (4 uC, 12,0006g/min). The supernatant was saved for qPCR analyses.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AllGlo Probe Quadruplex Quantitative PCR</head><p>Primer and probe design. Conserved regions sequences of the four HPV type-specific genes were obtained from Gene Bank. After sequence comparison by CLUSTRALW software, the most conservative regions were used to design the primers and probes with Primer Premiers 5.0. By BLAST sequence comparison, the primers and probes with the best specificity were selected. The primers and AllGlo probes used in the multiplex qPCR were synthesized by Chaoshi Bio-company (Shanghai, China). To ensure the specificity and sensitivity of the multiplex qPCR, all primers and probes were designed to have similar Tm <ref type="table" target="#tab_0">(Table 1)</ref>. To enhance the hybridization specificity of each probe to its cognate target sequence, each probe was designed to have at least nine mismatched base pairs with its noncognate targets sequence.</p><p>Determination of the specificity and the sensitivity of the primer and the probe. To determine the specificity and the sensitivity of the primer and the probe, the uniplex fluorescence quantitative PCR experiments were first carried out on a Qiagen Rotor Gene 6000 fluorescence quantitative PCR instrument, which can simultaneously detect five wavelengths. Parameter variables such as cycle temperatures, concentration of primers and probe, the detection limit and replicating steps were all optimized. For every reactions, each 25-ml PCR reaction contained 11 ml of deionized water,10 ml of 2 6 qPCR Mix (Chaoshi Bio-company, Shanghai, China), 1 ml individual HPV plasmid DNA template <ref type="table" target="#tab_0">(-from 10</ref> 2 copies/ml to10 5 copies/ml), 2 ml primer (1 ml forward primer, 1 ml reverse primer)and 1 ml probe (four primer/probe combinations and concentrations: 400 nM/400 nM, 400 nM/ 200 nM, 200 nM/200 nM, or 200 nM/100 nM). Each PCR reaction was performed in triplicate. A blank plasmid without an HPV DNA insert and other HPV types DNA (genotypes identified through HPV GA test and Sanger sequencing,except HPV genotypes 6, 11, 16, 18, such as HPV genotypes 32, 39, 52, 58 etc.) was used as a negative control, and deionized water was used as the no-DNA blank control. The cycling conditions were a 5-min incubation at 95uC followed by 45 temperature cycles moving between 95uC for 10 s and 52uC for 20 s (During the cycling phase, the optimization annealing temperatures were varied from 52 to 66uC in single-degree increments). The specificity and sensitivity of primers and probes were determined according to the lowest Ct value, the highest gain in fluorescence and detection limit of the uniplex fluorescence qPCR, and the quadruplex qPCR described in the following sections referred to the parameters of the uniplex fluorescence qPCR.</p><p>Optimization of quadruplex quantitative PCR. Thanks to the specificity of the primer and the probe we selected here, we found we could take conditions such as the primer/probe combinations form uniplex assay to multiplex directly. Then we optimized annealing temperature (from 52uC260uC) and determined the compromise annealing temperature used for multiplex detection was 58?.</p><p>Quadruplex quantitative PCR was performed in the same manner as the uniplex qPCR assay described above, PCR mixtures contained 10 ml of 2 6 qPCR Mix, 1 ml individual HPV plasmid DNA temple (from 10 2 copies/ml to10 5 copies/ml), 8 ml mixture of all four sets of primers and 4 ml mixture of all four sets of probes (four primer/probe combinations and concentrations: 400 nM/400 nM, 400 nM/200 nM, 200 nM/200 nM, or 200 nM/100 nM), 2 ml of deionized water. Other parameter such as cycle temperatures, annealing temperatures and replicating steps were chosen from the uniplex qPCR. Each PCR reaction was performed in triplicate. The negative and blank control test of quadruple qPCR were performed in the same manner as the uniplex qPCR.</p><p>Determination of the specificity and sensitivity of quadruplex quantitative PCR. Four individual HPV plasmid DNA stocks and one mixed stock that comprised all four types HPV plasmids DNA were made with concentrations ranging from 1.0 6 10 1 copies/ml to 1.0 6 10 5 copies/ml. A 1-ml sample of the stock was used as the template for quadruplex fluorescence quantitative PCR. A blank plasmid without an HPV DNA insert and other HPV types DNA (except HPV genotypes 6, 11, 16, 18, such as HPV genotypes 32, 39, 52, 58 etc.) was used as a negative control, and deionized water was used as the no-DNA blank control. Fluorescence qPCR test was carried out in triplicate to (1) determine the minimum detection limit of this method, (2) determine the detection sensitivity and specificity of fluorescence quantitative PCR for the four types of HPV and (3) construct standard curves.</p><p>Standard curve for quadruplex quantitative PCR. Each quantitative PCR reaction, which was used to construct a standard curve, contained mixture of the four types of HPV plasmids (The concentration of each HPV types was equal) at final concentrations (copies/ml) of 10 , and 10 7 , as well as primers and probe at optimized concentrations and combinations. The qPCR assay were performed in duplicate, and a standard curve was constructed by the instrument's software.</p><p>The replicability test of quadruplex quantitative PCR. Five aliquots plasmids DNA were made from the mixed stock of four types HPV plasmids and stored at -20 uC, The selected concentrations of each HPV type were 10 2 , 10 4 , 10 6 ,and 10 8 (copies/test). Five side-by-side quadruplex quantitative PCR assay were carried out using the aliquots plasmids DNA in triplicate to determine the mean Ct value. The CV% between each aliquot was calculated to determine the replicability of our method.</p><p>Detection of clinical specimens. 270 clinical samples conserved at -80 uC whose HPV genotype and viral loads (only HPV6, 11, 16 and 18) had been previously determined were divided into nine groups <ref type="table" target="#tab_1">(Table 2)</ref>, each group contained 30 samples. DNA was extracted from these samples with a Da'an extraction kit (Guangzhou Da'an Diagnostic Co. Ltd., Guangzhou, China.). The extracted DNA was divided into five aliquots. Two aliquots were used for the detection of HPV6-11 and HPV16-18 mixed types by TaqMan uniplex probe fluorescence quantitative PCR (Guangzhou Da'an Diagnostic Co., Ltd., China). The third aliquot was used for the detection of HPV 6, 11, 16 and 18 with AllGlo probe quadruplex fluorescence qPCR. The fourth aliquot was used for the HPV genotype detection with HPV GA test again. The remaining aliquot was conserved at -80 uC to further verify the specificity of the quadruplex fluorescence qPCR method, and the same amount of DNA template was used in each experiment. The result was determined only when all parallel detection results were consistent. Finally, the results obtained by the quadruplex qPCR were compared with the results obtained with the uniplex TaqMan qPCR and HPV GA test.   </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Concentrations and Combinations of the Primer and the Probe, Annealing Temperature</head><p>Titrations of primer/probe combinations gave a positive result in uniplex qPCR and Quadruplex qPCR. The 400/200 combination had the highest amplification efficiency and the lowest Ct value ( <ref type="table" target="#tab_2">Table 3</ref>). The optimum annealing temperatures (uC) for HPV 6, 11, 16 and 18 amplification were: 60, 58, 58 and 58, respectively. In quadruplex fluorescence quantitative PCR, the compromise annealing temperature used for multiplex detection was 58uC, the primer/probe combinations was 400/200 (nM).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Specificity, Sensitivity and Replicability of Quadruplex Fluorescence Quantitative PCR</head><p>All of the four HPV types in quadruplex qPCR were detected positively, while the other type of HPV were negative in the same detection system <ref type="figure" target="#fig_3">(Figure 2</ref>). The sensitivities (copies/test) for HPV 6, 11, 16, and 18 were 10 1 , 10 2 , 10 1 , and 10 2 respectively <ref type="table" target="#tab_4">(Table 4</ref>).The detection result of quadruplex qPCR is consistent with the uniplex qPCR(P.0.05). The coefficients of variation (CVs) of the five parallel tests for the four types of HPV plasmids were all below 5% <ref type="table" target="#tab_4">(Table 4</ref>).  Five side-by-side AllGlo quadruplex quantitative PCR assay were carried out using the DNA aliquots in triplicate to determine the mean CT value, and the mean CT value was used for statistics of coefficient of variation (%) for four HPV types. *copies/test. # Intra-assay coefficient variation. Inter-assay coefficient variation. doi:10.1371/journal.pone.0048972.t004</p><p>Preparation of a Standard Curve </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results of Clinical Specimens Detection</head><p>The results obtained with AllGlo quadruplex fluorescence qPCR, HPV GA test and TaqMan uniplex qPCR method were summarized in <ref type="table" target="#tab_1">Table 2</ref>.The agreement rate between AllGlo quadruplex fluorescence qPCR, HPV GA test and TaqMan uniplex qPCR was 100%. Single-tube AllGlo probe quadruplex fluorescence qPCR could simultaneously type HPV 6, 11, 16, and 18 and quantitatively detect the viral load of each HPV at the same time. The detection sensitivity of AllGlo probe quadruplex fluorescence qPCR was higher than that of HPV GA test and TaqMan uniplex qPCR.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>The fluorescence PCR technique is becoming increasingly important in the diagnosis of human diseases, such as influenza virus, avian flu virus <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b30">31]</ref>, cytomegalovirus (CMV) <ref type="bibr" target="#b31">[32]</ref>, and severe acute respiratory syndrome (SARS) virus <ref type="bibr" target="#b32">[33]</ref>. Fluorescence PCR has advantages over conventional PCR <ref type="bibr" target="#b33">[34,</ref><ref type="bibr" target="#b34">35]</ref>.The former generates an amplification kinetics curve, which directly reflects the dynamic changes of the PCR process in real time. With the development of molecular biology and molecular marker techniques, multiplex fluorescence quantitative PCR technology is becoming more widely used. Multiplex PCR not only significantly reduces the workload but also increases the accuracy and comparability of the experiment. Methodologically, the multiplex fluorescence quantitative PCR technique is also suitable for HPV viral load and genotyping detection, especially for detecting a large number of samples simultaneously.</p><p>Quantitative PCR has been developed based on conventional PCR techniques. The quantitation of DNA or RNA templates is achieved by determining how many cycles are needed to reach a certain level of fluorescence. Currently used probes in fluorescence PCR include TaqMan probes, FRET probes, molecular signal probes, new fluorescent double-stranded replacement probes <ref type="bibr" target="#b35">[36,</ref><ref type="bibr" target="#b36">37]</ref> and AllGlo probes. FRET probes are not commonly used in real-time monitoring but are used in melting-point analysis and genotyping after the completion of PCR amplification <ref type="bibr" target="#b37">[38]</ref>. It is difficult to achieve the specificity in genotyping with conventional TaqMan probes; MGB was reported to enhance the specificity. However, MGB increases the cost and the difficulties in probe design and synthesis <ref type="bibr" target="#b38">[39]</ref>. Molecular signal probes have complicated designs when used in genotyping, and they are also inefficient in single-base discrimination <ref type="bibr" target="#b39">[40]</ref>. Currently, the most widely used probe in the clinical laboratory is TaqMan. However, it is difficult to design TaqMan experiments to detect multiple targets simultaneously, and this seriously limits the application of real-time PCR in genotyping <ref type="bibr" target="#b40">[41,</ref><ref type="bibr" target="#b41">42]</ref>.</p><p>The AllGlo probe is the latest generation of quantitative fluorescent probes invented by AlleLogic Biosciences Corporation. AllGlo probes use two identical fluorophores that are specially selected in such a way that the two fluorophores are mutually quenched when both are conjugated to the probe oligonucleotide. Both fluorophores become dequenched when the probe is cleaved. This study, the AllGlo probe quadruplex quantitative PCR was performed to simultaneously detect and differentiate human papillomavirus genotypes 6, 11, 16 and 18. Samples of four types of HPV (HPV 6, 11, 16, and 18) were PCR-amplified and sequence-confirmed in order to ensure the reliability of the fluorescence qPCR. Plasmids containing the target gene were cloned by T-A cloning for the preparation of standard DNA stock. By optimizing the concentrations and combinations of primers and probes in AllGlo quadruplex quantitative PCR, we finally resolved the issue of mutual interference among primers in multiplex PCR and established a single-tube quadruplex fluorescence quantitative PCR technique based on the AllGlo probe. This new approach allows simultaneous detection and typing of four HPV types in a single tube. The r 2 values of all of the standard curves were larger than 0.99, and the amplification efficiency was between 0.91 and 1.23, which meets the requirement for fluorescence quantitative PCR standard curves <ref type="bibr" target="#b42">[43,</ref><ref type="bibr" target="#b43">44]</ref>. The agreement rate between AllGlo quadruplex fluorescence qPCR, HPV GA test and TaqMan uniplex qPCR was 100%. Single-tube AllGlo probe quadruplex fluorescence qPCR could simultaneously type HPV 6, 11, 16, and 18 and quantitatively detect the viral load of each HPV at the same time. Compared with the HPV GA test and TaqMan uniplex qPCR method, the AllGlo quadruplex qPCR method enjoys a high sensitivity and a wide linear range. In our experiment, the sensitivity of quadruplex fluorescence quantitative PCR can reach 10 to100 copies/test, while the sensitivity of HPV GA test and TaqMan uniplex qPCR method was above 100 copies/test. For the same sample, the positive rate and accuracy of the AllGlo quadruplex qPCR method was higher than those of the HPV GA test and TaqMan uniplex qPCR method. In addition, AllGlo probe quadruplex fluorescence quantitative PCR also has the advantages of relatively high throughput, time savings, simple operation, and lower cost, which are key factors that are needed in order to be qualified for clinical applications. The repeatability, sensitivity and specificity were high enough to be qualified for both qualitative and quantitative detection in clinical settings.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p>AllGlo quadruplex quantitative PCR has the advantages of relatively high throughput, good reproducibility, high sensitivity, high specificity, and a wide linear range of detection. The convenient single-tube format makes this assay a powerful tool for the study of mixed infections caused by multiple pathogens, viral typing and viral load quantification,meanwhile, this method could be used in single nucleotide polymorphism (SNP) and mutation analysis, prenatal diagnosis and genetic disease screening, drug efficacy analysis, tumor gene expression detection, and so on. The assay will facilitate molecular epidemiological studies and drug development.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head><p>Supporting Information S1 The DNA target sequences of HPV <ref type="bibr">(HPV 6,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b17">18)</ref>  </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Figure 1. AllGlo probe fluorogenic detection systems for quantitative PCR. The advantage of AllGlo probe is brighter than TaqMan, no inhibition, higher specificity than TaqMan, easier multiplexing probe design. doi:10.1371/journal.pone.0048972.g001</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 2 .</head><label>2</label><figDesc>Figure 2. Specificity test of AllGlo probe quadruplex fluorescence quantitative PCR method. The concentration of each four HPV plasmid mixture (HPV 6, 11, 16, and 18) was 10 5 copies/test.HPV6-red (URA),HPV11-no markers (MAR),HPV11-circles (NEP), HPV18-crosses (JUP). doi:10.1371/journal.pone.0048972.g002</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><label></label><figDesc>inserted in plasmid was confirmed by Sanger sequencing. (DOC) Author Contributions Conceived and designed the experiments: LL. Performed the experiments: DY SW BW. Analyzed the data: DY YC Y-WT. Contributed reagents/ materials/analysis tools: DY SW BW. Wrote the paper: DY. Differentiation of HPV Genotypes Using AllGlo qPCR PLOS ONE | www.plosone.org</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0" validated="false"><head>Table 1 .</head><label>1</label><figDesc>The advantage of AllGlo probe is brighter than TaqMan, no inhibition, higher specificity than TaqMan, easier multiplexing probe design. doi:10.1371/journal.pone.0048972.g001Primers and probes of four types of HPV for AllGlo quadruple quantitative PCR.</figDesc><table>Gene ID 

Target 
gene 
Primers 
Primer sequences 
Probe 

Product 
Length (Bp) 

FM897165.1 
L1 
HPV6F 
HPV6R 

GTTATCGCCTCCCCCAAAT 
ATCTGGCTTTTCCTTTTCAGG 

URA-CCATTACCTGTCAAAAGCCCAC-URA 
103 

AF217526.1 
L1 
HPV11F 
HPV11R 

TTGCGAAAGGAACAAATGTTT 
GGAAGACACCAATGAGCCACT 

MAR-TGGGGGAACCTGTGCC-MAR 
159 

EU869318.1 
E6 
HPV16F 
HPV16R 

AGGACCCACAGGAGCGAC 
AGTCATATACCTCACGTCGCAGT 

NEP-ATGCACAGAGCTGCAAACAA-NEP 
126 

EU834744.1 
L1 
HPV18F 
HPV18R 

GGTTCAGGCTGGATTGCG TACACGCACACGCTTGGC 
JUP-TCGCAAACGTTCTGCTCC-JUP 
100 

URA, MAR, NEP and JUP are different AllGlo probe fluorochromes, URA is red fluorochromes, MAR is green fluorochromes, NEP is orange fluorochromes, JUP is yellow 
fluorochrome. By BLAST sequence comparison, the specificity of primers were depermined. 
doi:10.1371/journal.pone.0048972.t001 </table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1" validated="false"><head>Table 2 .</head><label>2</label><figDesc>Comparative results of HPV GA test, TaqMan uniplex qPCR and AllGlo quadruplex qPCR.The agreement rate between AllGlo quadruplex fluorescence quantitative PCR, HPV GA test and TaqMan uniplex qPCR was 100%. Single-tube AllGlo probe quadruplex fluorescence quantitative PCR could simultaneously type HPV 6, 11, 16, and 18 and quantitate the viral load of each HPV at the same time. Compared with the HPV GA test and TaqMan uniplex qPCR method, the AllGlo quadruplex qPCR method enjoys a high sensitivity and a wide linear range. For the same sample, the positive rate and accuracy of the AllGlo quadruplex qPCR method was higher than those of the HPV GA test and TaqMan uniplex qPCR method.</figDesc><table>HPV TYPE 
HPV GA test 

TaqMan 
uniplex qPCR 

AllGlo quadruplex 
qPCR 

6 
11 
16 
18 
others 
6-11 
16-18 
6 
11 
16 
18 

6 
2 8 
0 
0 
0 
0 
2 8 
0 
2 9 
0 
0 
0 

1 1 
0 
2 8 
0 
0 
0 
2 6 
0 
0 
2 8 
0 
0 

16 
0 
0 
29 
0 
0 
0 
27 
0 
0 
28 
0 

1 8 
0 
0 
0 
2 8 
0 
0 
2 6 
0 
0 
0 
2 8 

6+11 
28 
29 
0 
0 
0 
28 
0 
28 
28 
0 
0 

16+18 
0 
0 
27 
28 
0 
0 
27 
0 
0 
27 
28 

6+11+16 
26 
27 
27 
0 
0 
27 
27 
27 
27 
26 
0 

6+11+16+18 
27 
27 
27 
28 
0 
27 
28 
28 
28 
27 
29 

Others 

# 

0 
0 
0 
0 
3 0 
0 
0 
0 
0 
0 
0 

# Others:other HPV type,including 
HPV31,33,35,39,42,43,44,45,51,52,53,56,58,59,66,68,CP8304. 
doi:10.1371/journal.pone.0048972.t002 </table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2" validated="true"><head>Table 3 .</head><label>3</label><figDesc>Comparison of sensitivity and detection limit between TaqMan uniplex qPCR and AllGlo Quadruplex qPCR.</figDesc><table>HPV 
TYPE 

10 

1 

copies/test 

10 

2 

copies/test 

10 

3 

copies/test 

10 

4 

copies/test 

10 

5 

copies/test 

uniplex qPCR 
(Ct*) 

Quadruplex qPCR 

(Ct) 

uniplex 
qPCR 
(Ct) 

Quadruplex 

qPCR (Ct) 

uniplex qPCR 

(Ct) 

Quadruplex 

qPCR (Ct) 

uniplex qPCR 

(Ct) 

Quadruplex 

qPCR (Ct) 

uniplex qPCR 

(Ct) 

Quadruplex qPCR (Ct) 

6 

0 

0 

3 1 . 1 62.2 

31.862.3 

27.261.8 

28.161.7 

24.861.6 

25.161.5 

21.861.2 

21.661.3 

11 

33.961.6 

34.561.8 

29.661.3 

29.861.2 

25.761.1 

26.161.3 

22.460.8 

22.861.0 

18.960.6 

18.560.7 

1 6 

0 

0 

3 0 . 1 61.6 

31.161.8 

26.561.5 

26.961.7 

22.961.1 

22.761.2 

19.861.0 

19.961.2 

18 

33.061.9 

33.561.6 

29.961.5 

30.161.6 

26.161.2 

26.261.2 

22.660.9 

22.161.0 

19.360.8 

18.960.9 

Others# 

</table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4" validated="true"><head>Table 4 .</head><label>4</label><figDesc>Results of replicability test of AllGlo quadruplex qPCR.</figDesc><table>Concentration* 
HPV6 
HPV11 
HPV16 
HPV18 

Intra 

# 

Inter 
Intra 
Inter 
Intra 
Inter 
Intra 
Inter 

10 

2 

,1.1 
1.43 
,1.16 
0.90 
,1.31 
1.00 
,1.39 
1.02 

10 

4 

,0.86 
0.78 
,1.25 
0.95 
,1.27 
0.96 
,1.46 
1.23 

10 

6 

,1.21 
0.80 
,1.07 
0.79 
,1.21 
0.99 
,1.26 
0.86 

10 

8 

,1.17 
0.97 
,0.92 
0.72 
,1.96 
1.12 
,1.16 
0.95 

</table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | www.plosone.org</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">November 2012 | Volume 7 | Issue 11 | e48972</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">HPV prevalence and type distribution in women with or without cervical lesions in the Northeast region of Romania</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">G</forename><surname>Ursu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Onofriescu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Nemescu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">S</forename><surname>Iancu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virol J</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">558</biblScope>
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">External genital warts: diagnosis, treatment, and prevention</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Wiley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Douglas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Beutner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Fife</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="210" to="224" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Einstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Baron</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Levin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Chatterjee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Fox</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011" />
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1359" to="1373" />
			<pubPlace>Hum</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Comparison of the novel human papillomavirus 4 auto-capillary electrophoresis test with the hybrid capture 2 assay and with the PCR HPV typing set test in the detection of highrisk HPV including HPV 16 and 18 genotypes in cervical specimens</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">H</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Korean Med Sci</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="579" to="584" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Hiller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Poppelreuther</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Stubenrauch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Iftner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1262" to="1267" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">V</forename><surname>Sahasrabuddhe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Luhn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Wentzensen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Future Microbiol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1083" to="1098" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Associations of human leukocyte antigen class II genotypes with human papillomavirus 18 infection and cervical intraepithelial neoplasia risk</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">C</forename><surname>Chuang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">Y</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="223" to="231" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected men</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Jong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">C</forename><surname>Van Gorp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">W</forename><surname>Mulder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Tol</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">H</forename><surname>Smits</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J STD AIDS</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="262" to="264" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Fontaine</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Hankins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Money</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Rachlis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Pourreaux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Virol</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="307" to="312" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">HPV vaccine against anal HPV infection and anal intraepithelial neoplasia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Palefsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">R</forename><surname>Giuliano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Goldstone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">D</forename><surname>Moreira</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Aranda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">365</biblScope>
			<biblScope unit="page" from="1576" to="1585" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States-National Health And Nutrition Examination Survey</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">F</forename><surname>Dunne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Sternberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">E</forename><surname>Markowitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Mcquillan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Swan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="page" from="562" to="565" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
	<note>: opportunity to measure HPV vaccine impact?</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Castellsague</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Munoz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Pitisuttithum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Ferris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Monsonego</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="28" to="37" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">M</forename><surname>Neuzil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Canh Do</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">D</forename><surname>Thiem</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Janmohamed</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">M</forename><surname>Huong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="page" from="1424" to="1431" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">R</forename><surname>Giuliano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Palefsky</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Goldstone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">D</forename><surname>Moreira</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Penny</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">364</biblScope>
			<biblScope unit="page" from="401" to="411" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Mu Oz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Kjaer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Sigurdsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><forename type="middle">E</forename><surname>Iversen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Hernandez-Avila</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="325" to="339" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Sexual behaviour and HPV infections in 18 to 29 year old women in the pre-vaccine era in the Netherlands</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">H</forename><surname>Lenselink</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">J</forename><surname>Melchers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">G</forename><surname>Quint</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Hoebers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Hendriks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">3743</biblScope>
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">HPV molecular assays: defining analytical and clinical performance characteristics for cervical cytology specimens</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Shen-Gunther</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu</forename><forename type="middle">X</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gynecol Oncol</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="263" to="271" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Molecular methods for a correct diagnosis of multiple HPV infections and clinical implications for vaccine</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Tinelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Leo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Dell&amp;apos;edera</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Storelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">M</forename><surname>Galante</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Gynecol Cancer</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="545" to="550" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Diagnostic methods and techniques in cervical cancer prevention Part II: Molecular diagnostics of HPV infection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Vince</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">Z</forename><surname>Lepej</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Glas Ljek komore Zenicko-doboj kantona</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="18" to="25" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Molecular detection and genotyping of human papillomavirus in cervical carcinoma biopsies in an area of high incidence of cancer from Moroccan women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">M</forename><surname>Khair</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Mzibri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Mhand</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Benider</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Benchekroun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Virol</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="678" to="684" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">C</forename><surname>Swan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">H</forename><surname>Lum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">E</forename><surname>Sefers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="4157" to="4162" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Development and evaluation of a new detection tool-visual DNA microarray for simultaneous and specific detection of human immunodeficiency virus type-1 and hepatitis C virus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">L</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Biol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="5341" to="5348" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Multiplex fluorescent quantitative PCR for detecting deep fungal infection in patients with systemic lupus erythematosus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">D</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Zeng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nan Fang Yi Ke Da Xue Xue Bao</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="2112" to="2114" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">A novel multiplex real-time RT-PCR assay with FRET hybridization probes for the detection and quantitation of 13 respiratory viruses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Lassauniere</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kresfelder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Venter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol Methods</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="page" from="254" to="260" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Multiplex quantitative competitive polymerase chain reaction based on a multianalyte hybridization assay performed on spectrally encoded microspheres</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">P</forename><surname>Kalogianni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">S</forename><surname>Elenis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">K</forename><surname>Christopoulos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Ioannou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anal Chem</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="6655" to="6661" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Scheungraber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Herrmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Teller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Gajda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Virol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="302" to="307" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Multiplex fluorescent RT-PCR to quantify leukemic fusion transcripts</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Dupont</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Goldsborough</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Levayer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Savare</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Rey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biotechniques</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page">164</biblScope>
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Molecular beacon-based real-time PCR method for detection of 15 high-risk and 5 low-risk HPV types</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Takcs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Jeney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Kovcs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Mzes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Benczik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol Methods</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="153" to="162" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Development of a real-time multiplex PCR assay for the detection of multiple Salmonella serotypes in chicken samples</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>O&amp;apos;regan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Mccabe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Burgess</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Mcguinness</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Barry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Microbiol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">156</biblScope>
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">A FRET based melting curve analysis to detect nucleotide variations in HA receptor-binding site of H5N1 virus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">De</forename><surname>Santis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Faggioni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Ciammaruconi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Fillo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Clausi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Probes</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="298" to="302" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Design of multiplexed detection assays for identification of avian influenza a virus subtypes pathogenic to humans by SmartCycler real-time reverse transcription-PCR</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Mardi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Tsai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="86" to="92" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">QuanQuantitation of cytomegalovirus (hCMV) DNA and beta-actin DNA by duplex real-time fluorescence PCR in solid organ (liver) transplant recipients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>H Nfler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">A</forename><surname>Kreuzer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Laurisch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Rayes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Neuhaus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Microbiol Immunol</title>
		<imprint>
			<biblScope unit="volume">192</biblScope>
			<biblScope unit="page" from="197" to="204" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">A novel coronavirus associated with severe acute respiratory syndrome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">G</forename><surname>Ksiazek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Erdman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Goldsmith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">R</forename><surname>Zaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Peret</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="page" from="1953" to="1966" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Ante-and post-mortem diagnosis of rabies using nucleic acid-amplification tests</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Wacharapluesadee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Hemachudha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Expert Rev Mol Diagn</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="207" to="218" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Development of a real-time multiplex PCR assay for detection of viral pathogens of penaeid shrimp</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Pang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Xie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Virol</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="2245" to="2251" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">New approach to real-time nucleic acids detection: folding polymerase chain reaction amplicons into a secondary structure to improve cleavage of Forster resonance energy transfer probes in 5&apos;-nuclease assays</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">V</forename><surname>Kutyavin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page">29</biblScope>
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Templated chemistry for sequence-specific fluorogenic detection of duplex DNA</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">M</forename><surname>Franzini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Bruner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">T</forename><surname>Kool</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chembiochem</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="2132" to="2137" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">A miniaturised integrated biophotonic point-of-care genotyping system</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Girkin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">I</forename><surname>Mohammed</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">M</forename><surname>Ellis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Faraday Discuss</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="115" to="123" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Quantitative detection method for Roundup Ready soybean in food using duplex real-time PCR MGB chemistry</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Samson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Gull</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Marmiroli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Sci Food Agric</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="1437" to="1444" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Silicon-based biosensors for rapid detection of protein or nucleic acid targets</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Jenison</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>La</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Haeberli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Ostroff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Polisky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chem</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1894" to="1900" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Ruel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Fujimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Hatano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Yukl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Virol Methods</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="page" from="115" to="120" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Application of semi-quantitative M gene-based hydrolysis probe (TaqMan) real-time RT-PCR assay for the detection of peste des petits ruminants virus in the clinical samples for investigation into clinical prevalence of disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Balamurugan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Sen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Venkatesan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Yadav</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Bhanot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transbound Emerg Dis</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="383" to="395" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Revisiting the sigmoidal curve fitting applied to quantitative real-time PCR data</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Swillens</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Dessars</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">E</forename><surname>Housni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anal Biochem</title>
		<imprint>
			<biblScope unit="volume">373</biblScope>
			<biblScope unit="page" from="370" to="376" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Unreliable real-time PCR analysis of human endogenous retrovirus-W (HERV-W) RNA expression and DNA copy number in multiple sclerosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Garson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">F</forename><surname>Huggett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>Bustin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">W</forename><surname>Pfaffl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Benes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS Res Hum Retroviruses</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="377" to="378" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
